Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Similar documents
Maruti Suzuki. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

Ashok Leyland. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Bharat Petroleum Corporation

Tata Motors. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Thermax. Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research

Bharat Electronics. Best defence play. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Britannia Industries

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Eicher Motors. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

Hindalco Industries. Source: Company Data; PL Research

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Ultratech Cement. Source: Company Data; PL Research

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Jindal Steel & Power

Mphasis. Source: Company Data; PL Research

Tata Motors. Turnaround 2.0, Fit for future; BUY. Source: Company Data; PL Research

Dr. Lal PathLabs. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

Indraprastha Gas. Source: Company Data; PL Research

Maruti Suzuki (MSIL IN)

Glenmark Pharmaceuticals

Source: Company Data; PL Research

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research

HDFC Standard Life Insurance

NIIT Technologies. Source: Company Data; PL Research

Source: Company Data; PL Research

Larsen & Toubro. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

ICICI Prudential Life Insurance

Jindal Steel & Power

LIC Housing Finance. Source: Company Data; PL Research

GMR Infrastructure. Airport revenues on a thaw, Power awaiting its turn. Q3FY13 Result Update

Britannia Industries

VRL Logistics. Steady show in tough environment. Source: Company Data; PL Research

TVS Motors (TVSL IN)

NIIT Technologies. Source: Company Data; PL Research

Mindtree. Source: Company Data; PL Research.

Dabur India. Source: Company Data; PL Research

Need to pull up the socks. Source: Company Data; PL Research

Dr. Reddy's Laboratories

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

Hindustan Zinc. Strong show, H2 to be stronger than H1. Source: Company Data; PL Research

Gujarat State Fertilisers & Chemicals

FY20E FY21E FY20E FY21E

Tata Steel. Source: Company Data; PL Research

Glenmark Pharmaceuticals

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

Bayer Cropscience (BYRCS IN)

Cadila Healthcare. Source: Company Data; PL Research

Cig volumes surprise. Source: Company Data; PL Research

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Bharat Forge. Strong traction in exports. (our estimate Rs730m). Source: Company Data; PL Research

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

Punjab National Bank

Dr. Reddy's Laboratories

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Punjab National Bank

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

Larsen & Toubro (LT IN)

Aurobindo Pharma. Source: Company Data; PL Research

Transcription:

In a league of its own ; Buy October 28, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs8,115 Target Price Rs9,250 Implied Upside 14.0% Sensex 33,157 Nifty 10,323 (Prices as on October 27, 2017) Trading data Market Cap. (Rs bn) 2,450.7 Shares o/s (m) 302.0 3M Avg. Daily value (Rs m) 3444.9 Major shareholders Promoters 56.21% Foreign 25.29% Domestic Inst. 11.46% Public & Other 7.04% Stock Performance (%) 1M 6M 12M Absolute 4.9 27.4 38.5 Relative (1.5) 17.0 19.7 How we differ from Consensus EPS (Rs) PL Cons. % Diff. 2019 339.9 323.0 5.2 2020 398.7 390.3 2.1 Price Performance (RIC: MRTI.BO, BB: MSIL IN) (Rs) 9,000 8,000 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 Oct 16 Dec 16 Source: Bloomberg Feb 17 Apr 17 Jun 17 Aug 17 Oct 17 It is safe to say that Maruti Suzuki s (MSIL s) Q2FY18 result surpassed expectations. The beat was on account of higher than estimated gross margins which was partially offset by lower than expected other income. Overall revenue growth for the quarter was up 21.2% YoY at Rs217.7bn, with absolute EBITDA up 21% YoY at Rs36.8bn (PLe: Rs30.9bn) and EBITDA margins at 16.9% (PLe: 14.3%), down 10bps YoY/ up 360bps QoQ. With higher tax rate and lower non operating income, net profit for MSIL stood at Rs24.8bn, up 3.6% YoY and ahead of our estimate of ~Rs21bn. EBITDA margins at 16.9% improved 360 bps sequentially on back of a favourable product mix with new premium products contributing ~60 65% of sales, lower discounting, operating leverage and favourable forex movement. However, margins were marginally impacted by commodity cost pressure and higher advertisement expenditure. Competitive intensity fading, Maruti Suzuki continuing to gain market share and further intensifying its hold on the domestic PV market with successful product launches, underlines MSILs strong competitive position. However, near term capacity constraints are a slight dampener. We expect revenue CAGR of 13.6% over FY18 20e and with an adjusted profit CAGR of 17.1%, and an EBITDA CAGR of 16.4 % over the same period. We marginally increase our volume estimate by 2%/1.4% for FY18/19, resulting in an EBITDA increase of 4%/4.1% for FY18/19. The stock is currently trading at 23x FY18e EPS and 21x FY19e EPS. We value the stock at 25x Sep19e and arrive at a target price of Rs9,250 (previously Rs8,193) and upgrade MSIL to Buy. Contd...2 Key financials (Y/e March) 2017 2018E 2019E 2020E Revenues (Rs m) 680,348 796,780 906,044 1,028,120 Growth (%) 18.2 17.1 13.7 13.5 EBITDA (Rs m) 102,494 122,755 143,548 166,236 PAT (Rs m) 73,377 87,023 102,652 120,422 EPS (Rs) 243.0 288.2 339.9 398.7 Growth (%) 36.4 18.6 18.0 17.3 Net DPS (Rs) 75.0 90.0 100.0 101.0 Profitability & Valuation 2017 2018E 2019E 2020E EBITDA margin (%) 15.1 15.4 15.8 16.2 RoE (%) 22.2 22.2 22.4 22.3 RoCE (%) 22.0 21.9 22.1 22.1 EV / sales (x) 3.6 3.1 2.7 2.4 EV / EBITDA (x) 24.0 19.9 17.0 14.6 PE (x) 33.4 28.2 23.9 20.4 P / BV (x) 6.8 5.8 5.0 4.2 Net dividend yield (%) 0.9 1.1 1.2 1.2 Source: Company Data; PL Research Q2FY18 Result Update Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. Please refer to important disclosures and disclaimers at the end of the report

MSIL s total income grew a strong 22% YoY to Rs217.7bn (above exp of ~Rs216.2bn). This was on the back of 17.6% YoY volume growth and 3.6% YoY improvement in realizations. Export revenue for the quarter stood at Rs15.65bn, flat YoY but up 16% QoQ. EBITDA growth was robust at 21% YoY to Rs36.8bn (exp Rs30.9bn) with EBITDA margin dipping a slight 10bps YoY but higher 360bps QoQ at 16.9%, ahead of our expectations of 14.3%. Gross margins were lower 110bps YoY but higher 120bps QoQ. Staff cost as a % of sales increased 20bps YoY but was down 60bps QoQ while other expenses as a % of sales lowered 120bps YoY and 180bps QoQ. The sequential improvement in margins was mainly on account of a favourable product mix with new products forming ~60 65% of total volumes, lower discounting, operating leverage and favourable forex. Margins were impacted YoY by commodity cost pressures as well as higher advertisement expenses which were somewhat offset by cost reduction measures. With higher depreciation provision and effective tax rate (at 29% in Q2FY18 against 25% in Q2FY17) along with lower non operating income (down ~36% YoY), net profit for MSIL stood at Rs24.8bn, up 3.6% YoY (PLe: ~Rs21bn). Conference call highlights: The company has guided FY18 volumes to be ~1.7mn units (~9% YoY growth). Blended discounts in Q2FY18 were at Rs15,200/vehicle v/s Rs16,600/vehicle in Q1FY18. With commodity costs on an upward trajectory, the company has cautioned of higher raw material costs in H2FY18. For Q2FY18, volumes from SMG stood at ~34K units (Q1FY18 volumes were at ~24K units) and are expected to improve to 10.5K/month during Q3 and 20K units per month by Q4. Total FY18 production from SMG is expected to be ~150K units. Overall inventory at the dealer level is expected to be ~80 85K by October end. Royalty for the quarter stood at Rs11.44bn v/s Rs8.86bn in Q1FY18. Share of first time buyers remains at ~50% of total sales in Q2FY18. Sales to govt employees has grown by ~20% YoY over Q2FY18 while sales to fleet owners has seen low single digit growth. Rural sales have increased 22% YoY over the quarter. Capex guidance for FY18 remains at ~Rs40 45bn, of which Q2FY18 capex was at ~Rs15bn. October 28, 2017 2

Exhibit 1: Q2FY18 Result Overview (Rs m) Y/e March Q2FY18 Q2FY17 YoY gr. (%) Q1FY18 H1FY18 H1FY17 YoY gr. (%) Net Revenues 217,682 178,428 22.0 175,457 393,139 327,875 19.9 Raw Materials 149,780 120,741 24.1 122,884 272,664 222,277 22.7 % of Net Sales 68.8 67.7 70.0 69.4 67.8 Personnel 6,666 5,191 28.4 6,521 13,187 10,981 20.1 % of Net Sales 3.1 2.9 3.7 3.4 3.3 Manufacturing & Other Exp 24,461 22,122 10.6 22,740 47,201 42,095 12.1 % of Net Sales 11.2 12.4 13.0 12.0 12.8 Total Expenditure 180,907 148,054 22.2 152,145 333,052 275,353 21.0 EBITDA 36,775 30,374 21.1 23,312 60,087 52,522 14.4 EBITDA Margin (%) 16.9 17.0 13.3 15.3 16.0 Depreciation 6,825 6,300 8.3 6,839 13,664 12,680 7.8 EBIT 29,950 24,074 24.4 16,473 46,423 39,842 16.5 Interest Expenses 150 197 (23.9) 313 463 378 22.5 Non operating income 5,229 8,126 (35.7) 6,827 12,056 13,007 (7.3) PBT 35,029 32,003 9.5 22,987 58,016 52,471 10.6 Tax Total 10,186 8,023 27.0 7,423 17,609 13,582 29.6 Tax Rate (%) Total 29.1 25.1 16.0 32.3 30.4 25.9 17.3 Reported PAT 24,843 23,980 3.6 15,564 40,407 38,889 3.9 Adj. PAT 24,843 23,980 3.6 15,564 40,407 38,889 3.9 Source: Company Data, PL Research Exhibit 2: Operating Metrics (Rs m) Y/e March Q2FY18 Q2FY17 YoY gr. (%) Q1FY18 H1FY18 H1FY17 YoY gr. (%) Car Sales Volume (nos) 492,118 418,470 17.6 394,571 886,689 766,913 15.6 Net Realisation/Vehicle 442,337 426,382 3.7 444,678 443,379 427,526 3.7 Material cost / vehicle 304,358 288,530 5.5 311,437 307,508 289,833 6.1 Gross Profit / vehicle 137,979 137,852 0.1 133,241 135,871 137,692 (1.3) Employee cost /vehicle 13,546 12,405 9.2 16,527 14,872 14,318 3.9 Other expenses / vehicle 49,706 52,864 (6.0) 57,632 53,233 54,889 (3.0) EBITDA/vehicle 74,728 72,583 3.0 59,082 67,766 68,485 (1.1) Net Profit/vehicle 50,482 57,304 (11.9) 39,445 45,571 50,708 (10.1) Source: Company Data, PL Research October 28, 2017 3

Income Statement (Rs m) Net Revenue 680,348 796,780 906,044 1,028,120 Raw Material Expenses 467,316 546,591 622,452 705,290 Gross Profit 213,032 250,189 283,592 322,830 Employee Cost 23,310 27,040 31,772 37,332 Other Expenses 87,228 100,394 108,272 119,262 EBITDA 102,494 122,755 143,548 166,236 Depr. & Amortization 26,021 27,017 28,932 29,955 Net Interest (514) (479) (864) (1,184) Other Income 22,798 24,799 27,430 30,293 Profit before Tax 99,413 120,865 142,572 167,253 Total Tax 26,036 33,842 39,920 46,831 Profit after Tax 73,377 87,023 102,652 120,422 Ex Od items / Min. Int. Adj. PAT 73,377 87,023 102,652 120,422 Avg. Shares O/S (m) 302.0 302.0 302.0 302.0 EPS (Rs.) 243.0 288.2 339.9 398.7 Cash Flow Abstract (Rs m) C/F from Operations 127,844 102,847 134,741 153,965 C/F from Investing (119,229) (75,000) (100,000) (110,000) C/F from Financing (8,875) (27,990) (30,867) (31,073) Inc. / Dec. in Cash (260) (143) 3,874 12,892 Opening Cash 391 131 14,988 18,862 Closing Cash 131 (12) 18,862 31,753 FCFF 90,913 78,204 89,124 108,444 FCFE 93,440 78,154 89,074 108,394 Key Financial Metrics Growth Revenue (%) 18.2 17.1 13.7 13.5 EBITDA (%) 15.8 19.8 16.9 15.8 PAT (%) 36.4 18.6 18.0 17.3 EPS (%) 36.4 18.6 18.0 17.3 Profitability EBITDA Margin (%) 15.1 15.4 15.8 16.2 PAT Margin (%) 10.8 10.9 11.3 11.7 RoCE (%) 22.0 21.9 22.1 22.1 RoE (%) 22.2 22.2 22.4 22.3 Balance Sheet Net Debt : Equity Net Wrkng Cap. (days) (33) (26) (26) (26) Valuation PER (x) 33.4 28.2 23.9 20.4 P / B (x) 6.8 5.8 5.0 4.2 EV / EBITDA (x) 24.0 19.9 17.0 14.6 EV / Sales (x) 3.6 3.1 2.7 2.4 Earnings Quality Eff. Tax Rate 26.2 28.0 28.0 28.0 Other Inc / PBT 22.9 20.5 19.2 18.1 Eff. Depr. Rate (%) 13.9 12.6 11.2 9.9 FCFE / PAT 127.3 89.8 86.8 90.0 Source: Company Data, PL Research. Balance Sheet Abstract (Rs m) Shareholder's Funds 361,711 421,554 494,006 583,926 Total Debt 4,836 4,786 4,736 4,686 Other Liabilities 4,640 1,000 1,000 1,000 Total Liabilities 371,187 427,340 499,742 589,612 Net Fixed Assets 145,415 148,398 164,467 179,512 Goodwill Investments 282,284 312,284 367,284 432,284 Net Current Assets (56,512) (33,343) (32,009) (22,184) Cash & Equivalents 131 14,988 18,862 31,753 Other Current Assets 77,251 101,874 114,604 128,388 Current Liabilities 133,894 150,204 165,475 182,326 Other Assets Total Assets 371,187 427,340 499,742 589,612 Quarterly Financials (Rs m) Y/e March Q3FY17 Q4FY17 Q1FY18 Q2FY18 Net Revenue 168,648 183,334 175,457 217,682 EBITDA 24,890 25,595 23,312 36,775 % of revenue 14.8 14.0 13.3 16.9 Depr. & Amortization 6,349 7,010 6,839 6,825 Net Interest 290 226 313 150 Other Income 5,919 4,491 6,827 5,229 Profit before Tax 24,170 22,850 22,987 35,029 Total Tax 6,725 5,745 7,423 10,186 Profit after Tax 17,445 17,105 15,564 24,843 Adj. PAT 17,445 17,105 15,564 24,843 Key Operating Metrics Total volumes (units) 1,568,603 1,774,127 1,962,937 2,160,252 Realisation per unit (Rs) 426,554 441,816 454,191 468,411 Gross margin per unit (Rs) 135,810 141,021 144,473 149,441 EBITDA per unit (Rs) 65,341 69,192 73,129 76,952 Profit per unit (Rs) 46,779 49,051 52,295 55,744 Source: Company Data, PL Research. October 28, 2017 4

Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai 400 018, India Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 Rating Distribution of Research Coverage PL s Recommendation Nomenclature % of Total Coverage 50% 40% 30% 20% 10% 0% 44.5% 39.1% 16.4% 0.0% BUY Accumulate Reduce Sell BUY : Over 15% Outperformance to Sensex over 12 months Accumulate : Outperformance to Sensex over 12 months Reduce : Underperformance to Sensex over 12 months Sell : Over 15% underperformance to Sensex over 12 months Trading Buy : Over 10% absolute upside in 1 month Trading Sell : Over 10% absolute decline in 1 month Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Mr. Saksham Kaushal (BSc Accounting & Finance (Hons.)), Ms. Poorvi Banka (MSc. Finance), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Saksham Kaushal (BSc Accounting & Finance (Hons.)), Ms. Poorvi Banka (MSc. Finance), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. DISCLAIMER/DISCLOSURES (FOR US CLIENTS) ANALYST CERTIFICATION The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report Terms & conditions and other disclosures: This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a 6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer. October 28, 2017 5